🔍 Pharmidex In Silico Drug Discovery – Step 3: Determination of Active/Binding Sites! 🎯💻
February 25, 2025

At Pharmidex, we continue to push the boundaries of computational drug discovery! Following target structure and ligand determination, our advanced Determination of Active/Binding Sites step ensures precise identification of key molecular interactions, optimizing drug design for success.


✨ Why is this step crucial?

✅ Accurate identification of binding pockets for targeted drug interactions

✅ AI-powered pocket detection and molecular dynamics simulations

✅ Enhanced precision in hit identification and lead optimization

✅ Seamless integration with our next in silico pipeline steps


By leveraging cutting-edge computational tools, we de-risk drug development and accelerate therapeutic innovation. Stay tuned for the next stage in our in silico pipeline!


📽️ Watch our latest video (2/5) to explore how we map active sites with precision!


📩 Let’s collaborate to revolutionize drug discovery!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation

December 16, 2025
We are pleased to share that Ian Knowles and Martin Barrett will attend Pharmacology 2025, organized by The British Pharmacological Society (BPS), at the ICC Belfast from 16–18 December 2025. They will host a Pharmidex exhibition stand, showcasing our key services and their importance in drug discovery and development. Ian and Martin will be delighted to meet attendees, exchange ideas, and explore new collaboration opportunities. Come and say hello!
December 8, 2025
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
December 3, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
More Posts